<Home> <Newsletter> <Third Issue> <Vaccine Safety> <Influenza A (H1N1) 2009 Monovalent>


Issue No. 003/09

20 November2009

 
Main Topic: H1N1 FLU (SWINEFLU)

VACCINE SAFETY

Influenza A (H1N1) 2009 Monovalent

FDA approved these vaccines as a strain change to each manufacturer’s seasonal influenza vaccine. There is considerable experience with seasonal influenza vaccine development and production and influenza vaccines produced by this technology have a long and successful track record of safety and effectiveness in the United States. The Influenza A (H1N1) 2009 Monovalent vaccines will undergo the usual testing and lot release procedures that are in place for seasonal influenza vaccines.

Injectable Vaccines

 

Intranasal Vaccine

 

Key Resources

 

Key Links



Contact

(800) 835-4709
(301) 827-1800
ocod@fda.hhs.gov
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448


 

 

IOMS Newsletter - 20 November 2009  
Issue No. 003/09
 
 
Back to Main Page (Contents) Back to Main Page (Contents)

Islamset Homepage